The impact of gender on presentation, therapy, and mortality of abdominal aortic aneurysm in the United States, 2001-2004  by McPhee, James T. et al.
From the New England Society for Vascular Surgery
The impact of gender on presentation, therapy,
and mortality of abdominal aortic aneurysm in the
United States, 2001-2004
James T. McPhee, MD,a Joshua S. Hill, MD,a and Mohammad H. Eslami, MD,b Worcester, Mass
Introduction: The elective repair of abdominal aortic aneurysms (AAA) may decrease a patient’s risk of rupture and
confers a significantly lower in-hospital mortality rate than emergency repair. Previous works have shown that AAA
rupture rates are higher in women compared to men, and that women have higher associated in-hospital mortality rates.
This study was performed to evaluate, currently, to what extent patient gender influences presentation and treatment of
AAA and the associated outcomes in the United States.
Methods: The Nationwide Inpatient Sample was used, with pertinent ICD-9 codes, to identify all patient-discharges that
occurred with the primary diagnosis of intact (iAAA) or ruptured/dissecting (rAAA) abdominal aortic aneurysms
between the years 2001 and 2004. Univariate and multiple logistic regression analyses of variables were performed.
Results: An estimated 220,403 AAA patient-discharges were identified during the study period. 37,016 (17%) patients
presented with rAAA. A higher percentage of women with AAA presented with rupture compared to men (21% vs 16%;
odds ratio [OR] 1.40, 95% confidence interval [CI], 1.27-1.54). This rupture rate did not significantly change from 2001
to 2004 (P  .85 for trend). For iAAA, women had higher odds of in-hospital mortality than men (OR 1.60; 95% CI,
1.24-2.07). Compared to men, in-hospital mortality rates for women with iAAA were higher for both endovascular (2.1%
vs 0.83%, P< .0001) and open repairs (6.1% vs 4.0%, P< .0001). For iAAA, fewer women underwent endovascular repair
(32.4% vs 46.7%, P < .0001; O.R. 0.59, 95% CI, 0.52-0.67). For patients who presented with rAAA, women were less
likely to undergo surgical intervention compared to men (59% vs 70%, P < .0001). For those that underwent repair,
women had higher in-hospital mortality rates than men (43% vs 36%, P < .0001; OR 1.49, 95% CI, 1.16-1.91).
Conclusion: A higher percentage of women currently present with aneurysm rupture. They have higher in-hospital
mortality rates for both iAAA and rAAA. This gender difference in the outcomes following repair of abdominal aortic
aneurysm has persisted over time, the cause of which is not explained by these or previous data, a fact that warrants further
investigation. (J Vasc Surg 2007;45:891-9.)It has been well documented that women have a higher
risk of rupturing abdominal aortic aneurysms (AAA) com-
pared to men.1-4 Reasons may include the possibility that
aneurysms of equal diameter may represent a greater pro-
portional dilatation in women compared to men,5 as well as
the possibility that women experience an accelerated
growth rate of AAA compared to men.6
Previous studies have recommended a lower thresh-
old for intervention of AAA for women due to concerns
about the demonstrated increased risk of rupture with its
attendant mortality rates.2,3,5,7 In 2003, this led to an
official joint commission recommendation for a smaller
threshold diameter of 4.5 to 5.0 cm for elective aneu-
rysmorrhaphy in women.8 Additionally, based on data
from the previous two decades, it has been shown that
for the repair of both intact (iAAA) and ruptured aneu-
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doi:10.1016/j.jvs.2007.01.043rysms (rAAA), women have substantially higher rates of
in-hospital mortality.2,9,10-14 More recently, using
Medicare data, limited to patients over age 65, other
authors have shown that these higher mortality rates for
women have persisted over the last decade.15,16
These recommendations from the previous decade for
earlier elective intervention in women with smaller aneu-
rysms may have impacted the proportion of women with
AAA that present with rupture. The objective of this study
was to determine, during a period (2001-2004) in which an
exclusive procedural code existed for endovascular aneu-
rysm repair, and using a comprehensive nationally represen-
tative all-payer database, to what extent gender affects the
presentation, treatment, and mortality for patients with
abdominal aortic aneurysm.
METHODS
This is a retrospective population based study from
administrative data obtained from the Nationwide Inpa-
tient Sample (NIS) for the years 2001 to 2004. The NIS is
the largest representative database of its kind.17 The NIS
uses a weighting strategy to allow national estimates to be
calculated. Sampled hospitals are given appropriate weights
based on the number of hospitals they represent in the
database for a given year.17 All data provided in the results
section are reported in this “weighted” form. The diagnos-
tic codes from the International Classification of Diseases
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used to identify all patient discharges with the principal
diagnosis of intact AAA (441.4) or ruptured/dissecting
AAA (441.3, 441.02). The cohort was further limited
based on ICD-9CM procedural codes to identify those
patients that underwent open aortic repair (OAR), (38.44,
39.25) or endovascular aortic repair (EVAR) (39.71). Be-
cause the ICD-9CM code specific to endovascular aortic
repair was not available until October, 2000,19 and the
procedure could have previously been coded under a mul-
titude of other nonspecific codes, for the purposes of ho-
mogeneity, the years prior to 2001 were excluded, as were
patients under the age of 40.
The primary outcome measure was in-hospital mortal-
ity, regardless of length of time from the initial procedure.
Secondary analyses included presentation type (iAAA vs
rAAA) as well as type of repair performed (OAR vs EVAR).
All data analyses were performed using the advanced survey
procedures in SAS version 9.1 (SAS Institute, Cary, NC).
Univariate analyses of categorical values were performed
using the Rao-Scott 2 test, with a P value.05 considered
significant.TrendanalyseswereperformedusingtheMantel-
Haenszel 2 test. Multiple logistic regressions were per-
formed with presentation type, in-hospital mortality, and
procedure type evaluated separately as dependent variables.
Independent variables included in the regressions were:
patient age, race, gender, insurance status, and selected
patient comorbid medical conditions (congestive heart fail-
ure [CHF], renal failure, valvular heart disease, chronic
lung disease, liver disease, hypertension, obesity, and dia-
betes mellitus).20 In addition, certain hospital level charac-
teristics including hospital teaching status, setting, and
hospital geographic region were included in the multivari-
ate logistic regression. These hospital level data are ob-
tained from the American Hospital Association database,
which is directly linked to the NIS by corresponding year.17
RESULTS
During the 4-year period of this study, an estimated
220,403 patient-discharges occurred for the principal diag-
nosis of abdominal aortic aneurysm in U.S. hospitals. The
annual incidence of AAA overall as well as iAAA and rAAA
remained nearly constant at approximately 55,000, 45,000
and 10,000, respectively per year, P  .50 for trend (Fig 1).
Overall, 183,387 (83.2%) were treated for intact abdomi-
nal aortic aneurysms while 37,016 (16.8%) were treated for
aneurysm rupture. Table I contains the patient characteris-
tics based on presentation for intact vs ruptured AAA and
includes the results of the univariate analysis of presentation
type by each characteristic.
Intact AAA
Of those patients undergoing surgery for iAAA (n 
146,684), the mean age was 72.3 (SEM 0.07), 80% were
men, and 91% were white. Overall 40.6% of patients with
iAAA were treated by endovascular means during the stud-
ied interval. There was an increasing trend in the usage ofEVAR from 33% in 2001 to 50% by 2004, P  .0001 for
trend (Fig 2).
Overall, in-hospital mortality was 3.1%. Open repair
(4.5%) conferred a higher mortality rate than endovascular
repair (1.0%) by univariate analysis, P  .0001 (Table II).
Of note, crude in-hospital mortality for iAAA was also
significantly greater for women, older patients, non-white
patients and those undergoing surgery in 2001 vs 2004
(Table II). By multivariate analysis, with patient death as
the dependent variable, factors independently predictive of
higher in-hospital mortality included; open repair (odds
ratio [OR] 3.68; 95% confidence interval [CI], 2.56-5.31),
female gender (OR 1.60; 95% CI, 1.24-2.07) non-white
race (1.52; 95% CI, 1.08-2.14), older patient age, and
pre-existing renal failure, congestive heart failure, or liver
disease (Table III).
Patient gender. Table IV contains a comparison of
patient characteristics by gender for the iAAA surgical
patients. For intact AAA, women had higher overall
mortality rates compared to men, 4.8 vs 2.6%, P 
.0001. This was true for both open and endovascular
procedures. By univariate analysis, for OAR, the mortal-
ity rate was higher for women compared to men, 6.1 vs
4.0%, P  .0001; as well as EVAR, 2.1% vs 0.83%, P 
.0001. On average, women were 2 years older than men.
They had higher rates of chronic lung disease (40.4% vs
32.6%, P  .0001) and hypertension (60.6% vs 56.6%, P
 .0001); however, they were similar in rates of valvular
heart disease, congestive heart failure, and renal failure,
the three comorbidities that were independently predic-
tive of higher in-hospital mortality on multivariate anal-
ysis. In the multivariate logistic regression for mortality
of iAAA, the odds of mortality in women was 1.6 (95%
CI, 1.24-2.07) times that of men despite adjustment for
age, race, procedure type (OAR vs EVAR), hospital
teaching type, year of surgery and medical comorbidities
Fig 1. This line graph demonstrates the overall annual incidence
of AAA as well as that for the intact and ruptured subgroups in the
United States, 2001-2004.(Table III). During the course of the study, for iAAA,
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2001 to 2.6% in 2004, P  .0001 for trend. The in-
hospital mortality rate for men decreased from 3.1% to
2.2%, P  .0001 for trend. During the same interval, the
mortality rate for women also decreased, but to less of a
degree going from 5.2% in the year 2001 to 4.2% in
2004, P  .003 for trend (Fig 3). In terms of operative
intervention for iAAA, women were less likely to un-
dergo EVAR compared to men (32.4% vs 46.7 %, P 
Table I. Characteristics of all AAA patients by presentatio
Intact (%)
No. patients 183,387 (83.2
Patient gender
Men 143,377 (78.2
Women 39,961 (21.8
Mean age [SEM] 72.7 [0.07]
Men [SEM] 72.2 [0.08]
Women [SEM] 74.5 [0.11]
Median age for men 73
Median age for women 75
Patient race
White 120,735 (89.3
Non-white 14,477 (10.7
Insurance
Private/Medicare 178,594 (96.4
Medicaid/self-pay 6,640 (3.6)
Comorbidities
Diabetes 21,953 (12.0
Congestive heart failure 3,757 (2.0)
Renal failure 7,799 (4.3)
Chronic lung disease 62,127 (33.9
Hypertension 104,281 (56.9
Liver disease 1,634 (.89)
Obesity 6,552 (3.6)
Valvular heart disease 1,799 (0.98
Fig 2. This bar chart demonstrates the shift in the percentage of
intact AAA cases performed endoluminally from 2001-2004. By
2004, 50% of cases were endovascular aortic repairs..0001). This was confirmed in a separate multivariatelogistic regression in which women had odds of EVAR
0.59 times that of men (95% CI, 0.52-0.67).
Ruptured AAA
Of the patients that presented with rAAA, 68% under-
e (iAAA vs rAAA); results of univariate analysis included
Ruptured (%) P value
37,016 (16.8)
.0001
26,319 (71.1)
10,698 (28.9)
73.2 [0.16] .0001
71.9 [0.18] .0001
76.2 [0.27] .0001
73
78
.0001
22,522 (84.3)
4,182 (15.7)
.0001
34,375 (93.0)
2,598 (7.0)
3,694 (10.0) .0001
2,057 (5.6) .0001
2,670 (7.2) .0001
11,025 (29.8) .0001
16,144 (43.6) .0001
325 (.88) .91
1,208 (3.3) .21
976 (2.6) .0001
Table II. Univariate analysis of in-hospital mortality for
operative patients
iAAA rAAA
Factor
%
Mortality
P
value
%
Mortality
P
value
Overall 3.1 37.3
Gender .0001 .0001
Men 2.6 35.6
Women 4.8 43.0
Age groups (y) .0001 .0001
60 .73 20.8
60-69 1.7 28.8
 70 3.9 43.2
Patient race .001 .41
Non-white 4.3 36.6
White 3.0 38.8
Patient insurance type .18 .053
Private 3.1 37.7
Medicaid/self-pay 2.4 31.4
Year of surgery .033 .12
2001 3.5 37.7
2002 3.1 40.0
2003 3.0 34.8
2004 2.6 36.3
Procedure type .0001 .0002
OAR 4.5 38.2
EVAR 1.0 29.0n typ
)
)
)
)
)
)
)
)
)went operative management. The operative group had an
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iAAA rAAA
Factor Odds ratio 95% Confidence interval Odds ratio 95% Confidence interval
Sex
Women (vs men) 1.60 1.24-2.07 1.49 1.16-1.91
Age group
70 (vs 60) 9.20 3.22-26.3 4.01 2.59-6.22
70 (vs 60-69) 2.11 1.55-2.86 2.03 1.53-2.70
Insurance type
Medicaid/self-pay (vs private) 0.90 .44-1.85 1.73 1.13-2.67
Procedure type
OAR (vs EVAR) 3.68 2.56-5.31 1.19 .805-1.77
Race
Non-white (vs white) 1.52 1.08-2.14 1.00 .708-1.42
Hospital teaching status
Non-teaching (vs teaching) .99 .785-1.24 1.12 .885-1.40
Year of surgery
2001 (vs 2004) 1.61 .357-7.25 1.06 .514-2.20
2002 (vs 2004) 1.58 .353-7.05 1.08 .514-2.28
2003 (vs 2004) .617 .050-7.62 1.05 .347-3.20
Comorbid conditions
Congestive heart failure (vs none) 7.77 4.17-14.5 .774 .382-1.57
Hypertension (vs none) 0.35 .272-.450 .566 .458-.699
Chronic lung disease (vs none) 1.13 .901-1.42 .578 .464-.720
Valvular heart disease (vs none) 2.04 .258-16.1 .709 .123-4.08
Liver disease (vs none) 4.26 1.93-9.39 5.07 1.77-14.5
Renal failure (vs none) 2.97 2.12-4.15 .906 .592-1.39
Diabetes (vs none) 1.00 .709-1.42 1.16 .801-1.69
Obesity (vs none) 1.03 .481-2.19 1.03 .587-1.81Table IV. Intact AAA surgical patient characteristics by gender (P value represents men vs women)
Factor Men Women Overall P value
No. patients (%) 117,306 (80.0) 29,377 (20.0) 146,684
Mean age [SEM] 71.9 [0.08] 73.9 [0.12] 72.3 [0.07] .0001
Race
% Non-white 9.10 10.9 9.50 .0015
% White 90.9 89.1 90.5
Insurance type
% Private/HMO 96.8 96.7 96.8 .68
% Medicaid/self-pay 3.20 3.30 3.20
Repair type .0001
% OAR 57.3 67.6 59.4
% EVAR 46.7 32.4 40.6
In-hospital mortality
% Overall 2.6 4.8 3.1 .0001
% EVAR 0.83 2.1 1.0 .0001
% OAR 4.0 6.1 4.5 .0001
Hospital type .47
% Teaching 57.7 57.1 57.6
% Non-teaching 42.3 42.9 42.4
Comorbidities
% Diabetes 12.4 9.9 11.9 .0001
% Obesity 3.8 3.9 3.8 .62
% Congestive heart failure 0.40 0.53 0.43 .19
% Renal failure 3.9 3.4 3.8 .08
% Chronic lung disease 32.6 40.4 34.2 .0001
% Hypertension 56.6 60.6 57.4 .0001
% Liver disease 0.89 0.70 0.86 .14
% Valvular heart disease .08 .12 .09 .27
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taken to surgery, 90% underwent open repair while 10%
underwent endovascular repair. The percentage of proce-
dures performed endoluminally increased from 6.2% in
2001 to 14.3% by 2004, P .0001 for trend. Of all patients
treated surgically for rAAA, the mean age was 72.3 years
(SEM  0.16), 78% were men, and 88% were white
(Table V).
On univariate analysis for rAAA mortality, the propor-
tion was significantly higher for women, older patients, and
patients undergoing open repair (Table II). Multivariate
analysis of mortality for the rAAA patients, seen in Table
III, revealed factors independently predictive of higher
odds of mortality for rAAA included female gender with
odds ratio 1.49 (95% CI, 1.16-1.91), and age 70 years
with an odds ratio 2.11 (95% CI, 1.55-2.86) compared
with those 60 to 69 years of age.
The univariate factors affecting AAA presentation type
showed that a greater percentage of the following patient
groups presented with aneurysm rupture: women, those
without private insurance, non-white patients, and those
with a history of CHF, renal failure, or valvular heart disease
(Table I). By multivariate analysis, the following remained
independently predictive of presenting with aneurysm rup-
ture: female gender, the lack of private insurance, non-
white patients, and the presence of CHF, renal failure, or
valvular heart disease (Table VI).
Patient gender. Of the men that presented with the
principal diagnosis of AAA, 15.5% presented with rupture.
By comparison, 21.1% of women presented with rupture (P
 .0001). Overall, women made up 23% of patients with
AAA, but represented a higher proportion of all patients
treated for rupture at 28.9% (P  .0001). These propor-
tions did not change over the 4- year period; of the women
with AAA,20 % consistently presented with rupture, P
Fig 3. This graph demonstrates the annual in-hospital mortality
rate for intact AAA overall, as well as that for women and men
individually from 2001-2004. The mortality rates have decreased
overall, as well as for both genders, however, the rate for women
remained 4% in 2004..85 for by trend test (Fig 4). By multivariate analysis of AAApresentation (ruptured vs intact), women had odds of
presenting with rupture 1.4 times that of men (95% CI,
1.27-1.54).
Of those that presented with a principal diagnosis of
rAAA, women were less likely to undergo surgical interven-
tion compared to men (59% vs 70%, P  .0001). This also
remained significant in the multivariate analysis in which
men were 1.4 times more likely to undergo surgical inter-
vention for rAAA compared to women (95% CI, 1.08-
1.71). For those that did undergo treatment for rAAA,
overall in-hospital mortality was greater for women (43% vs
35.6%, P  .0001). As shown in Table III, in the multivar-
iate logistic regression analysis for rAAA, after adjustment
for age, race, insurance, medical comorbidities as well as
hospital type, women had odds of mortality 1.49 that of
men (95% CI, 1.16-1.91).
DISCUSSION
Using data obtained from the Nationwide Inpatient
Sample for the years 2001-2004, the current work has
shown that, currently, despite an essentially unchanged
annual incidence in the number of patients treated for
abdominal aortic aneurysm, a higher proportion of women
with AAA present with rupture and continue to have overall
increased adjusted in-hospital mortality than men for iAAA
and rAAA (OR  1.5 for both). While an increasing
percentage of patients are undergoing EVAR over time,
which was associated with a significantly lower in-hospital
mortality rate, women are less likely to undergo endovas-
cular repair of their intact AAA.
The observed lower overall in-hospital mortality rate
for EVAR (1.0%) compared to OAR (4.5%) P  .0001 for
iAAA agrees with the findings of previous trials comparing
the two procedures. Notably in 2004, the investigators of
two randomized controlled trials found similar 30 day
mortality rates. The EVAR-1 trial reported significantly
lower 30 day mortality rates for EVAR (1.7%) compared to
open AAA repair (4.7%).21 These findings were confirmed
by the DREAM trial participants, who reported similar
mortality rates of 1.2% in the EVAR group and 4.6% in the
open repair group.22 Of note, the current work evaluates
in-hospital mortality, which may underestimate overall 30
day mortality rates, due to lack of follow-up data.
The demonstrated higher in-hospital mortality rate for
women with AAA in this study agrees with the findings of
several previous works.2, 9-16 Katz et al, using the Michigan
Inpatient Database in 1997, demonstrated a clear discrep-
ancy in operative mortality rates for men and women for
both intact and ruptured AAA. They concluded that the
data could not explain this difference but offered that a
delay in referral due to reliance on AAA diameter as the
universal indicator for surgery may be an important factor.2
Similarly, in 2001, Huber et al, published data from the
NIS (1994-1996) showing an increased mortality rate for
women as well, citing data for a potentially higher, unmea-
sured, percentage of juxtarenal aneurysms in the female
population as one possible explanation.10,23,24 The
gender-related differences in mortality outcomes observed
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While women, on average, were older than men for both
iAAA and rAAA, and age was an independently predictive
of higher mortality rates for both groups, patient age was
included in the multivariate logistic regression. Compared
to men, women had similar rates of congestive heart failure
and renal failure as well as slightly higher rates of hyperten-
sion and chronic lung disease however, patient medical
Table V. Ruptured AAA surgical patient characteristics by
Men
No. patients (%) 16,230 (77.5)
Mean age [SEM] 71.6 [0.18]
Race
% Non-white 12.3
% White 87.7
Insurance type
% Private/HMO 93.3
% Medicaid/self-pay 6.7
Repair type
% OAR 89.9
% EVAR 10.1
In-hospital mortality
% Overall 35.6
% EVAR 29.4
% OAR 36.3
Comorbidities
% Diabetes 8.6
% Obesity 3.6
% Congestive heart failure 2.0
% Renal failure 7.4
% Chronic lung disease 32.0
% Hypertension 38.0
% Liver disease 1.0
% Valvular heart disease 0.45
Table VI. Multivariate analysis of the presentation of
ruptured AAA
Factor
Odds
ratio
95% Confidence
interval
Gender
Women (vs Men) 1.40 1.27-1.54
Age group
60 (vs 70) 1.67 1.43-1.96
60-69 (vs 70) 0.87 .78-.97
Insurance type
Medicaid/self-pay (vs private) 1.72 1.41-2.10
Race
Non-white (vs white) 1.47 1.25-1.73
Hospital teaching status
Non-teaching (vs teaching) 1.41 1.22-1.62
Comorbid conditions
Congestive heart failure (vs none) 2.44 1.94-3.10
Hypertension (vs none) 0.61 0.55-0.67
Chronic lung disease (vs none) 0.86 0.78-0.95
Valvular heart disease (vs none) 1.94 1.39-2.71
Liver disease (vs none) 0.95 0.61-1.49
Renal failure (vs none) 1.29 1.07-1.56
Diabetes (vs none) 0.87 0.75-1.01comorbid conditions were also included in the multivariatelogistic regression of in-hospital mortality, which con-
firmed female gender as an independent risk factor for
mortality after aneurysm repair.
We exclusively utilized the years 2001 to 2004 for this
study. During this time, a specific ICD-9CM code (397.1)
existed for endovascular aortic repair. Treatment by EVAR
was independently predictive of decreased mortality on
multivariate analysis for iAAA mortality. Based on these
data, the limitation of access to endovascular technology
observed for women (32.4% vs 42.7%, P  .0001) is a
factor that may have contributed to their increased overall
mortality rate for iAAA compared to men (4.8% vs 2.6%, P
 .0001). The underlying cause for the lower proportion of
women treated by EVAR may be purely anatomical; the
relatively large diameter of the delivery sheaths may pre-
clude the use of these devices in the generally smaller native
access vessels of the female population.25,26 However de-
spite this anatomical constraint, some single institution
reports have shown that while complications arising from
endoluminal treatments may be more common in women
vs men,27 major outcome indicators such as all-cause mor-
tality and major complications are equivalent with
follow-up intervals as long as 5 years.28-30 Hopefully, the
knowledge of the results of the current work as well as
previous works will serve as an impetus for a focus of
research to develop smaller delivery devices specifically for
women with abdominal aortic aneurysms, helping to nar-
row the gender gap in terms of EVAR eligibility and overall
in-hospital mortality and access-related morbidity for
iAAA.
Our finding that women have a proportionally higher
der (P values represent men vs women)
Women Overall P value
4,703 (22.5) 20,932 (100)
74.8 [0.31] 72.3 [.16] .0001
15.5 13.0 .042
84.5 87.0
94.5 93.6 .23
5.5 6.4
.78
90.3 90.0
9.7 10.0
43.0 37.3 .0001
27.7 29.0 .75
44.7 38.2 .0001
10.1 8.9 .17
3.0 3.5 .34
2.3 2.1 .54
5.7 7.0 .08
34.4 32.6 .17
46.3 39.9 .0001
.75 .96 .44
0.51 0.47 .82genrisk of rupture for AAA is similar to that found in other
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small aneurysm trial, Brown et al reported that women have
a relative risk of rupture three times that of men.1 These
findings were cited in the 2003 recommendation by the
Joint Council of the American Association for Vascular
Surgery and Society for Vascular Surgery, which stated for
women with AAA, elective repair should be considered for
aneurysms 4.5 to 5.0 cm in diameter.8 These findings were
further corroborated by Dillavou et al in 2006, based on
administrative data from the Centers for Medicare Services,
which included the years 2000 to 2003,15,16 but was
limited to a cohort of single payer patients over 65 years.
Our findings, from a larger dataset which includes patients
under the age of 65 (20% of the total) and, which includes
uninsured patients (5% of total) independently confirms
those results. Recently, some institutionally based studies,
though limited by total patient number, have reported on
the increased rupture risk for women, concluding that AAA
of equal diameter may represent a greater proportional
dilatation in women,5 and that women possibly experience
an increased growth rate of their AAA.6
In the current work, we proposed that the dissemina-
tion of the knowledge about the recommendations of
previous studies dating back to the mid 1990s, ie, the
importance of earlier intervention in women with AAAmay
have impacted the rate at which women present with rup-
ture over time. In practice, if women were being referred
earlier for repair of smaller aneurysms, one may expect the
national proportion of those presenting with rupture to
decrease over time in relation to those undergoing intact
AAA repair. The results of this study show that the propor-
tion of women that presented with rupture did not decrease
over the 4-year interval. Instead, the proportion of women
presenting with rAAA remained persistently 20% while
Fig 4. This figure represents the percentage of aneurysms that
presented with rupture from 2001-2004 by patient gender. No
significant change occurred for either gender, with the proportion
of women with AAA presenting with rupture remaining 20%
each year.that for men remained nearly static at approximately 16%.These findings extend those found by Dillavou et al
through 2003,15,16 with the current work encompassing
the most recent available data shows this trend continues
through 2004. The etiology of this gender outcomes dis-
crepancy is impossible to prove based on the administrative
nature of these datasets. One explanation we offer may
include a possible disconnect between the knowledge base
of the vascular surgical and that of the referring medical
community31 in regard to the importance of these and
other results. Regardless, continued efforts should be made
to communicate this information to the primary care med-
ical community to ensure early referral when an aneurysm
of any dimension is detected in a woman.
One notable gender difference in AAA management
that could potentially impact the difference in rupture rates
as well as overall mortality rates is that currently no national
screening recommendations exist for women. Screening
trials performed inmen have shown to decrease rupture risk
by 50%32 and decrease the need for emergency operations
by 68%.33 Recommendations have been made to screen
men aged 65 to 75 as a means of reducing AAA-related
mortality in the United States,34 and similar results were
found by subgroup analysis in Western Australia.35 To our
knowledge, only one randomized trial dedicated to aneu-
rysm screening in women has been performed.36 Scott et al,
in a 2002 British study (n 9342), concluded that screen-
ing conferred no overall benefit as the incidence of rupture
was equivalent for those that were screened and those that
were not.36 Of note, the criteria for surgical intervention in
that study may not be generalizable to the US population,
which typically recommends undergoing elective repair at a
smaller diameter.8 Other authors have advocated initiating
screening programs in women. Recently, Wanhainen et al,
utilizing a Markov simulation model, determined that the
cost-effectiveness ratio of screening women, in terms of
cost per life year gained was equivalent to that of men, with
the lower prevalence of AAA in women being offset by the
increased rupture risk37 concluding that women should be
included in future AAA screening studies. Longo et al
found screening women who were at higher risk such as
smokers or those with a positive family history of AAA may
be beneficial.38 In light of these findings, a US based
randomized screening trial dedicated to women could be
helpful and may ultimately prove cost-effective.37
An additional unmeasured factor that may be limiting
access to timely surgical intervention for AAA in women
may be a gender bias at the referring physician and inter-
vening physician level. A significant gender bias against
women has been identified in terms of access to diagnostic
coronary angiography as well as percutaneous and surgical
revascularization for women with coronary artery disease.39
Because this bias has been identified in the cardiac surgical
arena, and due to the similarity of patient populations,
gender bias warrants consideration in the vascular surgery
discipline as well.
The limitations of administratively abstracted data are
well known, specifically in terms of the lack of information
on the severity of coded medical comorbidities and patient
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report information on race, which may lead to missing and
inaccurate data. In this study, the observation that non-
white patients presented with increased rupture rates and
had increased mortality rates for iAAA is qualified by the
fact that, of the total patient cohort, race data was not
available for 25% of patients. Further studies with more
complete data for those factors should be pursued to make
more accurate conclusions based on these findings. Simi-
larly, there is no information on patient stage of disease in
the NIS. In this study, aneurysm size, morphology, and
anatomical location are unknown, which are clearly impor-
tant factors when evaluating the presentation of ruptured
or asymptomatic aneurysms as well as vascular surgical
interventions and outcomes, particularly in the case of
access to endovascular modalities. The outcomemeasure of
in-hospital mortality is also a limited measure of overall
success. Ideally, 30 day mortality and all cause mortality as
well as major morbidity and postoperative complications
should be evaluated; however, they are unavailable in this
database. The main focus of this study was to evaluate the
effect of patient gender on presentation type, surgical in-
tervention, and in-hospital mortality as it relates to the
period in which an exclusive endovascular aortic repair
ICD-9CM code existed; all of which are variables more
reliably coded in the NIS from 2001to 2004.
CONCLUSION
In conclusion, we have added further evidence that
through 2004, women are still more likely to present with
ruptured abdominal aortic aneurysm compared to men.
This proportion has not decreased with time despite pub-
lished recommendations, including those by major vascular
societies, to intervene at a lower AAA size threshold for
women with this disease.8 Additionally, women continue
to have higher in-hospital mortality rates for ruptured AAA,
as well as for open and endovascular repair of iAAA, which
may have implications if more elective cases are performed
for smaller aneurysms in the future. The causal factors
underlying the effect of gender on mortality are not clearly
explained by the current or previous data, a fact that war-
rants further study. 29
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